Medanta enhances its urological expertise: Appoints leading surgeon Dr. Gagan Gautam and team to further strengthen its robotic uro-oncology surgery program
GURGAON, India, Feb. 6, 2023 /PRNewswire/ — Expanding its pool of clinical experts who deliver holistic, advanced healthcare, Medanta has appointed renowned robotic uro-oncological surgeon Dr. Gagan Gautam as Vice-Chairman of Uro-Oncology and Robotic Surgery. Dr. Gautam and his team of robotic surgery specialists – Dr. Puneet Ahluwalia (Director) and Dr. Gopal Sharma (Consultant) – have joined Medanta's accomplished clinicians at Kidney and Urology Institute, led by Group Chairman Dr. Rajesh Ahlawat. At the forefront of delivering cutting-edge treatments, the institute is one of the highest-volume robotic kidney transplant centers in India and is known for its exceptional success rate in robotic and laparoscopic uro-oncology procedures.
An accomplished robotic surgeon, Dr. Gautam has over two decades of experience in treating cancers of the urinary system, including kidneys, bladder, and prostate gland. Him and his team have done over 1,500 robot-aided uro-oncological surgeries, and specialize in robotic prostatectomy, robotic partial nephrectomy, and robotic cystectomy.
The team will further strengthen Medanta's collaborative approach of providing end-to-end diagnosis and treatment of urinary cancers with its extensive experience in minimally invasive (robotic and laparoscopic) and open surgeries, development of new treatment techniques, and initiating and developing urological robotic surgery programs all over the country.
“Appointment of senior doctors like Dr. Gagan Gautam and team is in line with our commitment to always deliver the highest standard of care by expanding our team of accomplished doctors. Strengthening our clinical leadership, we welcome Dr. Gautam and team to the Medanta family,” said Dr. Naresh Trehan, Chairman & Managing Director, Medanta.
(Disclaimer: The above press release comes to you under an arrangement with PRNewswire India and this publication takes no editorial responsibility for the same)
